# Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants

> **NCT03814642** · PHASE1 · COMPLETED · sponsor: **HK inno.N Corporation** · enrollment: 25 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Clopidogrel 75 mg
- **DRUG:** Tegoprazan 50 mg
- **DRUG:** Esomeprazole 20 mg

## Key facts

- **NCT ID:** NCT03814642
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-21
- **Primary completion:** 2019-07-22
- **Final completion:** 2019-07-22
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03814642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03814642, "Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03814642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*